Protagonist Therapeutics (PTGX) Reports Q4 Loss of $0.15
Get Alerts PTGX Hot Sheet
Join SI Premium – FREE
Protagonist Therapeutics (NASDAQ: PTGX) reported Q4 EPS of ($0.15), versus ($0.67) reported last year.
For earnings history and earnings-related data on Protagonist Therapeutics (PTGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gold Royalty Corp. (GROY) Tops Q4 EPS by 2c ; Offers Guidance
- urban-gro Inc. (UGRO) Misses Q4 EPS by 22c, offers outlook
- Franklin Covey (FC) Tops Q2 EPS by 1c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!